Treatment with JAK inhibitors in myelofibrosis patients nullifies the prognostic impact of unfavorable cytogenetics

MICRO ABSTRACT: In the era before the advent of JAK inhibitors, cytogenetic information was used to predict survival in myelofibrosis patients. However, the prognostic value of cytogenetics in the setting of JAK inhibitor therapy remains unknown. Our analyses suggest that initiation of JAK inhibitor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Ma, Vincent T., Boonstra, Philip S., Menghrajani, Kamal, Perkins, Cecelia, Gowin, Krisstina L., Mesa, Ruben A., Gotlib, Jason R., Talpaz, Moshe
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927833/
https://ncbi.nlm.nih.gov/pubmed/29574002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2018.02.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados